Concepedia

Publication | Open Access

Tiotropium Respimat Add-on Is Efficacious in Symptomatic Asthma, Independent of T2 Phenotype

DOIFull Paper Access

75

Citations

33

References

2017

Year

Thomas B. Casale, Eric D. Bateman, Mark Vandewalker, J. Christian Virchow, Hendrik Schmidt, Michael E. Engel, Petra Moroni-Zentgraf, Huib A.M. Kerstjens
The Journal of Allergy and Clinical Immunology In Practice

Abstract

The results of our exploratory analyses suggest that the improvements seen with tiotropium Respimat as add-on to ICS ± LABA in patients with symptomatic asthma on lung function, exacerbation risk, and symptom control are independent of T2 phenotype.

References

YearCitations

Page 1